Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 11, 2009, Pages 3504-3512

  Osada, Shiwori ^a   Hamada, Chieko ^a   Shimaoka, Tetsutaro ^a   Kaneko, Kayo ^a   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alfa SMA; Decorin; Hyaluronan; Peritoneal dialysis; Versican

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DECORIN; HYALURONIC ACID; PROTEOGLYCAN; VERSICAN; ACTIN; ALPHA SMA PROTEIN, HUMAN; ALPHA-SMA PROTEIN, HUMAN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; GELATINASE A; LEUKOCYTE ANTIGEN; SCLEROPROTEIN; VCAN PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADULT; AGED; CHEMISTRY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; UREMIA;

ACTINS; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; HYALURONIC ACID; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PROTEOGLYCANS; UREMIA; VERSICANS;

EID: 73949130387     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp268     Document Type: Article

References (24)

1. Dobbie JW, Anderson JD, Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int. 1994; 14(Suppl 3): S16-S20
2. Wight TN, Heinegard DK, Hascall VC et al. Proteoglycans: structure and function. In Hay E D (ed). Cell Biology of Extracellular Matrix. New York: Plenum, 1991, 45-78
3. Yung S, Thomas GJ, Stylianou E et al. Source of peritoneal proteo-glycans. Am J Pathol 1995; 146: 520-529
4. Margets PJ, Gyorffy S, Kolb M et al. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002; 13: 721-728
5. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281-284
6. Yamagata M, Kimata K. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci 1994; 107: 2581-2590
7. Wight TN, Merrilies MJ. Proteoglycans inathelosclerosis and resteno-sis. Circ Res 2004; 94: 1158-1167
8. Erdelyi I, Nieskens DHM, Dijk JE et al. Immunohistochemical evaluation of versican, in relation to chondroitin sulfate, in canine mammary tumors. Histol Histopath 2003; 18: 1067-1080
9. Takemura G, Fujiwara H, Mukoyama M. et al. Immunohistochemical localization and semi-quantification of atrial natriuremic polypeptide (ANP) in formalin-fixed-paraffin-embedded normal human hearts. Jpn Circ J 1989; 53: 686-694
10. Wiliams JD. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
11. Grant DS, Yenisely C, Rose RW et al. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002; 21: 4765-4777
12. Kimata K, Oike Y, Tani K et al. Alarge chondroitin sulfate proteglycan synthesized before chondrogenesis in the limb bud of chick embryos. J Biol Chem 1986; 261: 13517-13525
13. Bensadoun ES, Burke AK, Hogg JC et al. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154(Pt 1): 1819-1828
14. Ross R. Athelosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126
15. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF et al. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem 1996; 44: 303-312
16. HulangR, Merriees MJ, Braun K et al. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 2006; 98: 370-377
17. Kolodgie FD, Burke AP, Wight TN et al. The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of rupture. Curr Opin Lipid 2004; 15: 575-582
18. Toeda K, Nakamura K, Hirohata S et al. Versican is induced in infiltrating monocytes in myocardial infarction. Mol Cell Biochem 2005; 280: 47-56
19. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol. Chem 2002; 277: 4575-4579
20. Hirahara I, Ogawa Y, Kusano E et al. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats. Nephrol Dial Transplant 2004; 19: 1732-1741
21. Passi A, Negrini D, Albertini R et al. The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett 1999; 456: 93-96
22. Fukuda Y, Ishizaki M, Kudoh S et al. Localization of matrix metalloproteinases-1,-2, and-9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998; 78: 687-698
23. Chaponnier C, Desmouliere A, Gabbiani G. Tissue repair, contraction and the myofibroblast. Wound Repair Regen 2005; 13: 7-12
24. Muchaneta-Kubara EC, elNahas AM. Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transplant 1997; 12: 904-915